In May 2022, the Russian network of hospitals within the Global-PPS project published a new paper in the Tropical Medicine and Infectious Disease journal. The goal of the study was to evaluate prescribing patterns of antimicrobials in COVID-19 patients in several Russian multi-field hospitals, and to quantify the prescribing in relation to quality indicators.
At the 32st edition of the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), the Global-PPS team from the University of Antwerp and participants from Georgia, Montenegro, and the Philippines present their latest Global-PPS results. This year, ECCMID will take place for the first time as a hybrid event both online and on-site in Lisbon, Portugal on 23 – 26 April 2022.
Evaluating the Global Point Prevalence Survey of antimicrobial consumption and resistance in 47 Canadian hospitals
On December 21, 2021, a network of Canadian hospitals published a paper in CMAJ Open, reporting on their Global-PPS results. This study describes antimicrobial use (AMU) based on detailed patient-level data in Canadian hospitals in 2018 in terms of antimicrobial prevalence, indications and agent selection in adult and paediatric medical, surgical and intensive care wards.
Africa CDC (Africa Centres for Disease Control and Prevention) and CDDEP (Center for Disease Dynamics, Economics & Policy) published the first edition of the African antibiotic treatment guidelines for common bacterial infections and syndromes.
The Global-PPS in Iran primarily started in 2015 in the Kurdistan University of Medical Sciences, concurrently with the first global attempt for data collection about antibiotic consumption conducted by the University of Antwerp, Belgium. From 2017, the Global-PPS was repeated every year with additionaldata collected in 4 new hospitals in Sanandaj.
For a long time, the overuse and inappropriate use of both antibiotics and antimalarial drugs has been observed. This poses a threat to the financial situation of this rural hospital. The problem is known, but behavioral change is challenging.
Implementation of a multidisciplinary antimicrobial stewardship programme in a Philippine tertiary care hospital
Optimizing antimicrobial prescribing in hospitals through antimicrobial stewardship (AMS) is essential in addressing the threat of antimicrobial resistance. This study reports the results of five consecutive PPS in a private tertiary hospital in the Philippines, using the Global-PPS protocol.
The Global-PPS team published a paper that focuses on the implementation of antimicrobial stewardship in hospitals in the Global Point Prevalence Survey of Antimicrobial Consumption and Resistance (Global-PPS) network.
Over the past few months, the Global-PPS team has been busy updating the real-time feedback report. They now also provide insight into prevalence’s for the different antibiotic subgroups, healthcare-associated infections and use of invasive devices and the novel WHO AWaRE classification.
On 5 April 2021, the Global-PPS team published a paper in the Journal of Antimicrobial Chemotherapy that focuses on hospital antibiotic prescribing patterns in adult patients according to the WHO Access, Watch and Reserve classification (AWaRe).
Dr. Irma Korinteli, a pediatrician and lecturer at Tbilisi State Medical University, has been involved in the Global-PPS project from the very beginning in 2015. Earlier this year, she successfully defended her PhD on antibiotic use in Georgian hospitals. Read her testimonial below!
The Global-PPS protocol is adapted to survey COVID-19 patients. The website is translated in French, Japanese, Russian and Spanish. More languages will follow. Read two nice stories on how the Global-PPS is rolled out at national level and how these data can be used for a PhD.
The Global-PPS in Iran primarily started in 2015 in two large Iranian University cities, namely Shiraz and Kurdistan Universities of Medical Sciences, concurrently with the first global attempt for data collection about antibiotic consumption conducted by the University of Antwerp, Belgium.